Results 171 to 180 of about 918,306 (202)
Some of the next articles are maybe not open access.
Renal Sympathetic Denervation in Rats
2015Experimental renal sympathetic denervation is a well-established technique. Classically, renal sympathetic denervation is achieved by dorsal rhizotomy. While more recently, direct renal sympathetic denervation is typically applied by stripping all visible renal nerve bundles followed by painting with a solution of 10 % phenol in ethanol to remove the ...
Masahiro, Eriguchi, Kazuhiko, Tsuruya
openaire +2 more sources
Renal Sympathetic Denervation: The Jury Is Still Out
Lancet, The, 2010Stella Douma, Michael Doumas
exaly +3 more sources
Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension [PDF]
Hypertension, 2011 Renal sympathetic hyperactivity is seminal in the maintenance and progression of hypertension. Catheter-based renal sympathetic denervation has been shown to significantly reduce blood pressure (BP) in patients with hypertension.
Whitbourn, Robert +32 more
exaly +3 more sources
Renal Sympathetic Denervation for Resistant Hypertension
Canadian Journal of Cardiology, 2013Resistant hypertension is an increasingly prevalent health problem associated with important adverse cardiovascular outcomes. The pathophysiology that underlies this condition involves increased function of both the sympathetic nervous system and the renin-angiotensin II-aldosterone system.
Michael, Froeschl +2 more
openaire +2 more sources
Update on Renal Sympathetic Denervation for the Treatment of Hypertension
Current Cardiology Reports, 2022Hypertension is a leading risk factor for all-cause mortality in adults; however, medication non-adherence and intolerance present an enormous treatment challenge. Given the critical role of renal sympathetic nerves in neurogenic control of blood pressure and pathophysiology of hypertension, renal sympathetic denervation (RDN) has been explored as a ...
Arundati Rao, Namrata Krishnan
openaire +2 more sources
Sympathetic renal denervation: Hypertension beyond SYMPLICITY
Cardiovascular Revascularization Medicine, 2013Despite a wide range of drug treatment for hypertension, resistant hypertension rates remain high. The Symplicity™ Renal Denervation System (Medtronic, Santa Rosa, CA), which creates renal nerve denervation, has shown initial success in lowering blood pressure among patients with resistant hypertension.
Israel M, Barbash, Ron, Waksman
openaire +2 more sources
Renal Sympathetic Denervation for the Treatment of Systemic Hypertension
Cardiology in Review, 2012Systemic hypertension is a common cardiovascular problem that often cannot be fully treated with existing nonpharmacologic and pharmacologic measures. A catheter-based strategy which denervates the renal afferent and efferent autonomic nervous system has been developed for the treatment of drug-resistant hypertension.
Gordon M, Burke +2 more
openaire +2 more sources
2014
Hypertension affects more than a quarter of the adult population worldwide and is a major risk factor for cardiovascular and kidney disease. Despite the availability of proven therapeutic approaches including lifestyle modification and the use of antihypertensive drugs, control rates for hypertension remain unsatisfactory across the globe.
openaire +1 more source
Hypertension affects more than a quarter of the adult population worldwide and is a major risk factor for cardiovascular and kidney disease. Despite the availability of proven therapeutic approaches including lifestyle modification and the use of antihypertensive drugs, control rates for hypertension remain unsatisfactory across the globe.
openaire +1 more source
Copeptin, resistant hypertension and renal sympathetic denervation
Biomarkers, 2016Renal denervation is used as a treatment option for patients with resistant hypertension. But only a subgroup of patients benefits from renal sympathetic denervation (RDN). Biomarkers might be helpful to identify patients who respond to RDN. Copeptin as a surrogate for vasopressin levels is increased in hypertension and other cardiovascular diseases ...
Marius, Schwerg +3 more
openaire +2 more sources
Percutaneous Renal Sympathetic Denervation: 2013 and Beyond
Canadian Journal of Cardiology, 2014Systemic hypertension affects almost a quarter of Canadian adults. Although most can achieve adequate blood pressure control using a combination of medical and lifestyle interventions, many have resistant hypertension and are unable to reach their target.
Michael Froeschl +2 more
openaire +2 more sources